Investigators Review Biodetection Technologies
By HospiMedica staff writers Posted on 14 Mar 2007 |
In an effort to detect biological threats quickly and accurately, a number of detection technologies have been developed. Rapid and efficient sensors are essential for effective defense against the emerging threat of bioterrorism and biological warfare.
Researchers from Lawrence Livermore National Laboratory (LLNL; Livermore, CA, USA) reviewed several of the latest technologies in the February 2007 issue of the British journal The Analyst, which appears online. This review article describes several recent immunosensing advances that are relevant to biothreat detection. These highly diverse examples are intended to demonstrate the breadth of these immunochemical sensing systems and platforms while highlighting those technologies that are suitable for pathogen detection.
It's important to provide a summary of the latest technologies and approaches for sensing systems and platforms that could lead to bioagent detectors for responders to use in the field, said LLNL's lead author Jeffrey Tok. Other authors include Nicholas Fischer and Theodore Tarasow of LLNL's BioSecurity and Nanosciences Laboratory.
One technique, described by Dr. Tok and colleagues, involves using a barcode system, similar to the barcodes used on retail products, to detect biological agents in the field. Nanowires built from sub-micrometer layers of different metals, including gold, silver, and nickel, are able to act as 'barcodes' for detecting a variety of pathogens, such as anthrax, smallpox, ricin, and botulinum toxin. The approach could simultaneously identify multiple pathogens via their unique fluorescent characteristics.
Another detection strategy involves the development of an electrical current-based readout of the nanowires for protein and virus sensing. The wires are arranged as field-effect transistors (FETs), where slight variations at the surface produce a change in conductivity. Developers of this technology predict that a high-density nanowire-circuit array geared toward pathogen detection could be built on a large scale suitable for biosecurity surveillance.
Physical, chemical, and optical properties that can be tuned to detect a particular bioagent are the key to microbead-based immunoassay sensing systems. A unique spectral signature or fingerprint can be tied to each type of bead. Beads have been joined with antibodies to specific biowarfare agents. This method has been demonstrated in the autonomous pathogen detection system (APDS), a technology developed by Lawrence Livermore researchers. APDS contains an aerosol collector to constantly 'inhale' particles from its surrounding environment for analysis.
Microarray-based immunoassay sensing approaches can be used to detect bacteria, such as the E coli recently found in spinach and other fresh-packed greens. This approach can differentiate pathogens from harmless bacteria. In an analogous technique called aptamer microarray, short single strand chains of DNA (less than 100 nucleotides) are developed that bind to target molecules and fold into complex structures. The folding event results in an easy-to-read electrical charge. This binding-induced signaling strategy is particularly well suited for sensing in complex samples.
In a whole-cell-based immunoassay sensing system, an engineered B lymphocyte cell in which both pathogen-sensing membrane-bound antibodies and an associated light-emitting reporting system are all expressed in vivo. The B lymphocyte cell-based sensing system, termed Canary, centers on an easily expressed calcium-sensitive bioluminescent protein from the Aequoria victoria jellyfish. When exposed to targeted biowarfare compounds, an increase in photons was observed within the B lymphocyte cells in a matter of seconds. The photon changes can be easily detected using an inexpensive optical system.
The ability to miniaturize and adapt traditional bench-top immunoassay protocols to a fully automated micro-or nano-fluidic chip holds tremendous promise to enable multiplex, efficient, cost-effective, and accurate pathogen sensing systems for both biodefense and medical applications, Dr. Tok said.
Related Links:
LLNL
Researchers from Lawrence Livermore National Laboratory (LLNL; Livermore, CA, USA) reviewed several of the latest technologies in the February 2007 issue of the British journal The Analyst, which appears online. This review article describes several recent immunosensing advances that are relevant to biothreat detection. These highly diverse examples are intended to demonstrate the breadth of these immunochemical sensing systems and platforms while highlighting those technologies that are suitable for pathogen detection.
It's important to provide a summary of the latest technologies and approaches for sensing systems and platforms that could lead to bioagent detectors for responders to use in the field, said LLNL's lead author Jeffrey Tok. Other authors include Nicholas Fischer and Theodore Tarasow of LLNL's BioSecurity and Nanosciences Laboratory.
One technique, described by Dr. Tok and colleagues, involves using a barcode system, similar to the barcodes used on retail products, to detect biological agents in the field. Nanowires built from sub-micrometer layers of different metals, including gold, silver, and nickel, are able to act as 'barcodes' for detecting a variety of pathogens, such as anthrax, smallpox, ricin, and botulinum toxin. The approach could simultaneously identify multiple pathogens via their unique fluorescent characteristics.
Another detection strategy involves the development of an electrical current-based readout of the nanowires for protein and virus sensing. The wires are arranged as field-effect transistors (FETs), where slight variations at the surface produce a change in conductivity. Developers of this technology predict that a high-density nanowire-circuit array geared toward pathogen detection could be built on a large scale suitable for biosecurity surveillance.
Physical, chemical, and optical properties that can be tuned to detect a particular bioagent are the key to microbead-based immunoassay sensing systems. A unique spectral signature or fingerprint can be tied to each type of bead. Beads have been joined with antibodies to specific biowarfare agents. This method has been demonstrated in the autonomous pathogen detection system (APDS), a technology developed by Lawrence Livermore researchers. APDS contains an aerosol collector to constantly 'inhale' particles from its surrounding environment for analysis.
Microarray-based immunoassay sensing approaches can be used to detect bacteria, such as the E coli recently found in spinach and other fresh-packed greens. This approach can differentiate pathogens from harmless bacteria. In an analogous technique called aptamer microarray, short single strand chains of DNA (less than 100 nucleotides) are developed that bind to target molecules and fold into complex structures. The folding event results in an easy-to-read electrical charge. This binding-induced signaling strategy is particularly well suited for sensing in complex samples.
In a whole-cell-based immunoassay sensing system, an engineered B lymphocyte cell in which both pathogen-sensing membrane-bound antibodies and an associated light-emitting reporting system are all expressed in vivo. The B lymphocyte cell-based sensing system, termed Canary, centers on an easily expressed calcium-sensitive bioluminescent protein from the Aequoria victoria jellyfish. When exposed to targeted biowarfare compounds, an increase in photons was observed within the B lymphocyte cells in a matter of seconds. The photon changes can be easily detected using an inexpensive optical system.
The ability to miniaturize and adapt traditional bench-top immunoassay protocols to a fully automated micro-or nano-fluidic chip holds tremendous promise to enable multiplex, efficient, cost-effective, and accurate pathogen sensing systems for both biodefense and medical applications, Dr. Tok said.
Related Links:
LLNL
Latest Technology News
- TAVR Reduces Heart Valve Replacement Mortality
- Comunicación de pacientes en coma mediante interfaz cerebro-computador
- Innovative Spectrograph Has Medical Applications
- Digital Planning System Integrated into PACS for Orthopedic Applications
- Varian Medical Systems Earns Top Marks in Oncology IT Study
- In-Home Medical Device Assist Health Management
- RIS Mammography Module Improves Screening Administration in Denmark
- Chart Scanning Program Optimizes Emergency Department Billing
- RIS Customized for Multiple Client Facilities
- Automatic Processing Module Enhances Digital Imaging Workflow
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreCritical Care
view channel
First-Of-Its-Kind AI-Powered Probability Scoring System Assesses Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction (HFpEF) is one of the most difficult types of heart failure to diagnose due to the intricate interaction between various clinical and echocardiographic factors.... Read more
AI-Assisted Colonoscopy Detects More Polyps but Has Modest Effect on Cancer Risk
Colorectal cancer is among the most common cancers in the Western world. Currently, screening is performed using a test that detects blood in the stool (FIT screening). If the test identifies a certain... Read more
Wearables Could Reduce Need for Continuous Blood Thinners in Patients with Atrial Fibrillation
Atrial fibrillation (AFib) is the most prevalent heart arrhythmia, affecting over 5 million individuals in the United States, with projections suggesting that number could rise to 12.1 million by 2030.... Read moreSurgical Techniques
view channel
Tiny Robotic Tools Powered by Magnetic Fields to Enable Minimally Invasive Brain Surgery
Over the past few decades, there has been a significant surge in the development of robotic tools designed to facilitate minimally invasive surgeries, improving recovery times and patient outcomes.... Read moreMagnetic Tweezers Make Robotic Surgery Safer and More Precise
Microrobots are small-scale robots designed using nanotechnology, and they hold significant potential for various medical applications, including surgery, targeted drug delivery, and biopsy.... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more